Vigorous Exercise Does Not Increase Long QTS-Associated Cardiac Event Rate
By Elana Gotkine HealthDay Reporter
WEDNESDAY, July 31, 2024 -- For individuals with phenotypic or genotypic long-QT syndrome (LQTS), LQTS-associated cardiac event rates are low and do not differ for those exercising vigorously or nonvigorously, according to a study published online July 25 in Circulation.
Rachel Lampert, M.D., from the Yale School of Medicine in New Haven, Connecticut, and colleagues enrolled individuals aged 8 to 60 years with phenotypic or genotypic LQTS from 37 sites in five countries in the National Institutes of Health-funded LIVE-LQTS study. Participants or parents answered questions about physical activity and clinic event surveys every six months for three years to examine whether vigorous exercise increases the risk for ventricular arrhythmias. Data were included for 1,413 participants, 52 percent of whom participated in vigorous exercise (55 percent competitively).
The researchers found that 37 individuals experienced the composite end point of sudden death, sudden cardiac arrest, ventricular arrhythmia treated by an implantable cardioverter defibrillator, and likely arrhythmic syncope, with overall event rates of 2.6 and 2.7 percent at three years in the vigorous and nonvigorous exercise groups, respectively. For the vigorous group versus the nonvigorous group, the unadjusted hazard ratio for experience of events was 0.97 (95 percent confidence interval, 0.57 to 1.67) and the adjusted hazard ratio was 1.17 (95 percent confidence interval, 0.67 to 2.04). In none of the groups or subgroups was vigorous or nonvigorous exercise found to be superior.
"These data can inform individualized shared decision-making conversations between patients and physicians on vigorous exercise participation in the context of overall expert assessment and management of LQTS," the authors write.
Several authors disclosed ties to the pharmaceutical and medical device industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted July 2024
Read this next
Rebound Weight Gain Common After Discontinuing Antiobesity Medications
FRIDAY, July 25, 2025 -- Antiobesity medications (AOMs) yield weight loss during use, followed by weight regain after discontinuation of treatment, according to a review published...
Patients Face High Out-of-Pocket Costs After Incident Cancer Diagnosis
FRIDAY, July 25, 2025 -- Patients face high out-of-pocket costs (OOPCs) after an incident diagnosis of cancer, with costs increasing with stage of diagnosis, according to a study...
Exposure to PFAS Mixtures Linked to Increased Odds of Type 2 Diabetes
FRIDAY, July 25, 2025 -- In multiethnic populations, exposure to per- and polyfluoroalkyl substance (PFAS) mixtures may be associated with increased odds of type 2 diabetes (T2D)...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.